Reading Room

Pittsburg Corning Plans to Pay Asbestos Victims $825 Million

Jon 9987

PPG Industries (Pittsburg Corning Corp.) and its insurers plan to pay out millions of dollars to victims of asbestos disease. In a bankruptcy reorganization plan filed with the Court for its approval, it was announced that PPG intended to pay out $825 Million in cash over the next 15 years.

Raptiva® Withdrawn From Market for High Risk of Fatal Brain Disease

Jon 6783

We are investigating cases in which Raptiva® users have experienced neurological changes including unusual weakness, loss of coordination and changes in vision.

On April 8, 2009, the drug manufacturer Genentech announced a phased withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market.
 

Hydroxycut® Products Withdrawn From Market After FDA Consumer Advisory Warning

Jon 6553

Jon L. Gelman  is investigating potential cases involving users of Hydroxycut® products who have experienced health problems that may include Rhabdomyolysis (muscle damage that can lead to kidney failure and other health problems), death, cardiovascular symptoms, hypertension, elevated liver enzymes that can indicate liver failure, kidney failure and seizures. 

Homeland Security Takes Lead in Flu Pandemic Pointing to Compensation Programs

Jon 5520

The U.S. Department of Homeland Security (USDHS) has emerged as the lead agency in directing a response to the potential swine flu pandemic. The agency is following a well defined plan published in 2005 to respond to the threat in an effort to secure the Nation's critical infrastructure and key resources (CI/KR).

Is The Recovery Of The Workers’ Compensation System An Illusion?

Jon 3204

The present economic downturn has been compared to the Great Depression of the 1930’s or the recession of the 1980’s. The factors that existed during those financial cycles need to be compared to the present political and economic dynamic to determine whether or not history is repeating itself. Analysis of those two periods provides an insight as to whether or not there will be a rebound or surge of claims in the future.

First34568101112Last

CONTACT US
1.973.696.7900
jon.gelman@gmail.com